| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 71 | 2025 | 385 | 16.520 |
Why?
|
| Neonatal Screening | 37 | 2025 | 66 | 11.900 |
Why?
|
| Parents | 50 | 2025 | 292 | 11.110 |
Why?
|
| Living Donors | 41 | 2023 | 349 | 10.200 |
Why?
|
| Decision Making | 45 | 2025 | 674 | 7.850 |
Why?
|
| Kidney Transplantation | 39 | 2024 | 873 | 7.530 |
Why?
|
| Genetic Testing | 43 | 2025 | 565 | 7.430 |
Why?
|
| Tissue and Organ Procurement | 35 | 2025 | 389 | 6.890 |
Why?
|
| Child | 123 | 2025 | 7361 | 5.770 |
Why?
|
| Periodicals as Topic | 16 | 2023 | 168 | 5.730 |
Why?
|
| Informed Consent | 45 | 2021 | 277 | 5.680 |
Why?
|
| Organ Transplantation | 16 | 2025 | 295 | 4.950 |
Why?
|
| Attitude of Health Personnel | 26 | 2023 | 659 | 4.770 |
Why?
|
| Phenylketonurias | 12 | 2018 | 16 | 4.030 |
Why?
|
| Human Experimentation | 17 | 2022 | 39 | 3.890 |
Why?
|
| Tissue Donors | 21 | 2024 | 541 | 3.890 |
Why?
|
| Personal Autonomy | 26 | 2024 | 120 | 3.710 |
Why?
|
| Humans | 317 | 2025 | 93598 | 3.710 |
Why?
|
| Infant, Newborn | 53 | 2025 | 2479 | 3.310 |
Why?
|
| Ethics, Medical | 29 | 2023 | 296 | 3.290 |
Why?
|
| Kidney Failure, Chronic | 11 | 2020 | 430 | 3.270 |
Why?
|
| Bioethics | 10 | 2022 | 37 | 3.260 |
Why?
|
| Ethics, Research | 13 | 2018 | 53 | 3.090 |
Why?
|
| Cystic Fibrosis | 15 | 2025 | 119 | 3.060 |
Why?
|
| Parental Consent | 22 | 2020 | 36 | 2.980 |
Why?
|
| United States | 102 | 2025 | 7642 | 2.960 |
Why?
|
| Anemia, Sickle Cell | 10 | 2022 | 145 | 2.950 |
Why?
|
| Physician-Patient Relations | 16 | 2023 | 577 | 2.710 |
Why?
|
| Truth Disclosure | 9 | 2024 | 73 | 2.540 |
Why?
|
| Health Policy | 13 | 2021 | 207 | 2.380 |
Why?
|
| Adolescent | 58 | 2025 | 9611 | 2.330 |
Why?
|
| Youth Sports | 4 | 2020 | 8 | 2.280 |
Why?
|
| Moral Obligations | 10 | 2020 | 54 | 2.170 |
Why?
|
| Siblings | 8 | 2024 | 108 | 2.160 |
Why?
|
| Pediatricians | 4 | 2020 | 24 | 2.130 |
Why?
|
| Biomedical Research | 8 | 2020 | 434 | 2.100 |
Why?
|
| History, 20th Century | 19 | 2021 | 314 | 2.090 |
Why?
|
| Directive Counseling | 5 | 2020 | 34 | 2.040 |
Why?
|
| Treatment Refusal | 9 | 2024 | 68 | 2.030 |
Why?
|
| Genetic Counseling | 14 | 2025 | 101 | 1.990 |
Why?
|
| Bioethical Issues | 11 | 2020 | 39 | 1.930 |
Why?
|
| Confidentiality | 18 | 2015 | 75 | 1.920 |
Why?
|
| Authorship | 4 | 2023 | 26 | 1.910 |
Why?
|
| Patient Selection | 13 | 2018 | 690 | 1.870 |
Why?
|
| Ethics Committees, Research | 12 | 2023 | 34 | 1.780 |
Why?
|
| Risk Assessment | 31 | 2021 | 2444 | 1.760 |
Why?
|
| Sickle Cell Trait | 5 | 2013 | 21 | 1.730 |
Why?
|
| Physicians | 14 | 2023 | 683 | 1.720 |
Why?
|
| Brain Death | 5 | 2023 | 88 | 1.720 |
Why?
|
| Attitude | 9 | 2019 | 132 | 1.600 |
Why?
|
| Genetic Carrier Screening | 10 | 2011 | 58 | 1.600 |
Why?
|
| Female | 94 | 2025 | 48772 | 1.600 |
Why?
|
| Research Subjects | 12 | 2020 | 73 | 1.590 |
Why?
|
| Health Knowledge, Attitudes, Practice | 10 | 2018 | 559 | 1.590 |
Why?
|
| Family | 15 | 2023 | 323 | 1.560 |
Why?
|
| Disclosure | 9 | 2016 | 96 | 1.530 |
Why?
|
| Altruism | 8 | 2018 | 33 | 1.510 |
Why?
|
| Publishing | 6 | 2022 | 91 | 1.500 |
Why?
|
| Vaccination | 7 | 2025 | 303 | 1.480 |
Why?
|
| Social Justice | 8 | 2022 | 61 | 1.470 |
Why?
|
| Clinical Trials as Topic | 12 | 2021 | 1103 | 1.450 |
Why?
|
| Incidental Findings | 6 | 2015 | 97 | 1.450 |
Why?
|
| Genetic Diseases, Inborn | 7 | 2019 | 101 | 1.440 |
Why?
|
| Male | 80 | 2025 | 44576 | 1.440 |
Why?
|
| Withholding Treatment | 5 | 2020 | 121 | 1.430 |
Why?
|
| Family Relations | 7 | 2021 | 37 | 1.400 |
Why?
|
| Minors | 9 | 2020 | 15 | 1.370 |
Why?
|
| Data Collection | 15 | 2014 | 370 | 1.370 |
Why?
|
| Bibliometrics | 5 | 2023 | 45 | 1.330 |
Why?
|
| Morals | 6 | 2023 | 102 | 1.310 |
Why?
|
| Child Welfare | 8 | 2020 | 44 | 1.310 |
Why?
|
| Government Regulation | 10 | 2006 | 49 | 1.300 |
Why?
|
| Directed Tissue Donation | 5 | 2017 | 7 | 1.280 |
Why?
|
| Health Behavior | 3 | 2016 | 182 | 1.280 |
Why?
|
| Child Health | 2 | 2021 | 13 | 1.280 |
Why?
|
| Child Abuse | 4 | 2020 | 93 | 1.270 |
Why?
|
| Resource Allocation | 5 | 2019 | 64 | 1.270 |
Why?
|
| Patient Participation | 9 | 2020 | 230 | 1.260 |
Why?
|
| Brain Concussion | 4 | 2020 | 86 | 1.250 |
Why?
|
| Human Rights | 5 | 2018 | 20 | 1.240 |
Why?
|
| Community-Based Participatory Research | 4 | 2010 | 38 | 1.240 |
Why?
|
| Attitude to Health | 8 | 2010 | 217 | 1.240 |
Why?
|
| Transplant Recipients | 5 | 2025 | 159 | 1.230 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2019 | 624 | 1.190 |
Why?
|
| Mandatory Programs | 5 | 2025 | 8 | 1.150 |
Why?
|
| Athletic Injuries | 3 | 2020 | 103 | 1.140 |
Why?
|
| Prenatal Diagnosis | 6 | 2019 | 110 | 1.140 |
Why?
|
| Fragile X Syndrome | 5 | 2015 | 17 | 1.140 |
Why?
|
| Public Health | 4 | 2022 | 153 | 1.130 |
Why?
|
| Phenylalanine | 4 | 2018 | 32 | 1.130 |
Why?
|
| Ethical Analysis | 7 | 2022 | 23 | 1.110 |
Why?
|
| Biological Specimen Banks | 4 | 2012 | 72 | 1.100 |
Why?
|
| Muscular Dystrophy, Duchenne | 7 | 2015 | 39 | 1.090 |
Why?
|
| Policy Making | 10 | 2021 | 61 | 1.090 |
Why?
|
| Physician's Role | 5 | 2018 | 176 | 1.060 |
Why?
|
| Adolescent Health Services | 2 | 2024 | 13 | 1.050 |
Why?
|
| Therapeutic Misconception | 2 | 2021 | 5 | 1.050 |
Why?
|
| Adult | 54 | 2025 | 27947 | 1.030 |
Why?
|
| Waiting Lists | 14 | 2022 | 211 | 1.020 |
Why?
|
| Mental Competency | 10 | 2016 | 49 | 1.000 |
Why?
|
| Community-Institutional Relations | 4 | 2010 | 31 | 1.000 |
Why?
|
| Socioeconomic Factors | 7 | 2020 | 630 | 0.990 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2014 | 940 | 0.990 |
Why?
|
| Caregivers | 4 | 2025 | 179 | 0.990 |
Why?
|
| Vaccination Refusal | 3 | 2022 | 10 | 0.990 |
Why?
|
| Patient Advocacy | 5 | 2020 | 63 | 0.990 |
Why?
|
| Vulnerable Populations | 3 | 2020 | 91 | 0.990 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2021 | 589 | 0.980 |
Why?
|
| Heterozygote | 5 | 2012 | 381 | 0.980 |
Why?
|
| Research Design | 9 | 2021 | 620 | 0.910 |
Why?
|
| Pregnancy | 14 | 2024 | 3141 | 0.910 |
Why?
|
| Infant | 18 | 2025 | 3220 | 0.910 |
Why?
|
| Guidelines as Topic | 9 | 2020 | 163 | 0.910 |
Why?
|
| Child, Preschool | 20 | 2025 | 3833 | 0.890 |
Why?
|
| Clinical Decision-Making | 4 | 2024 | 290 | 0.890 |
Why?
|
| Nontherapeutic Human Experimentation | 4 | 2007 | 19 | 0.890 |
Why?
|
| Palliative Care | 3 | 2018 | 269 | 0.870 |
Why?
|
| Maple Syrup Urine Disease | 2 | 2018 | 5 | 0.870 |
Why?
|
| Parent-Child Relations | 11 | 2012 | 80 | 0.870 |
Why?
|
| Mothers | 7 | 2011 | 142 | 0.870 |
Why?
|
| Child Advocacy | 5 | 2011 | 8 | 0.860 |
Why?
|
| Surveys and Questionnaires | 17 | 2025 | 2804 | 0.860 |
Why?
|
| United Kingdom | 7 | 2024 | 190 | 0.860 |
Why?
|
| Vaccines | 2 | 2025 | 84 | 0.850 |
Why?
|
| Motivation | 5 | 2021 | 310 | 0.850 |
Why?
|
| Live Birth | 1 | 2024 | 22 | 0.850 |
Why?
|
| Death | 2 | 2018 | 97 | 0.840 |
Why?
|
| Research Personnel | 5 | 2015 | 78 | 0.830 |
Why?
|
| Mass Media | 2 | 2020 | 26 | 0.810 |
Why?
|
| Graft Survival | 8 | 2024 | 939 | 0.810 |
Why?
|
| Mass Screening | 4 | 2011 | 708 | 0.810 |
Why?
|
| Risk | 11 | 2016 | 657 | 0.810 |
Why?
|
| Research | 6 | 2005 | 251 | 0.790 |
Why?
|
| Registries | 5 | 2024 | 998 | 0.790 |
Why?
|
| Health Facilities | 1 | 2023 | 40 | 0.790 |
Why?
|
| Healthcare Disparities | 5 | 2023 | 498 | 0.780 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2023 | 247 | 0.780 |
Why?
|
| Minority Groups | 4 | 2006 | 149 | 0.770 |
Why?
|
| Schools | 2 | 2020 | 84 | 0.770 |
Why?
|
| ABO Blood-Group System | 7 | 2010 | 59 | 0.770 |
Why?
|
| Football | 3 | 2020 | 46 | 0.770 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2023 | 51 | 0.770 |
Why?
|
| Hematologic Tests | 1 | 2022 | 15 | 0.760 |
Why?
|
| Fetal Viability | 1 | 2022 | 11 | 0.750 |
Why?
|
| Heart Arrest | 2 | 2023 | 311 | 0.740 |
Why?
|
| Prisoners | 2 | 2018 | 47 | 0.740 |
Why?
|
| Life Support Care | 4 | 2018 | 54 | 0.740 |
Why?
|
| Chromosomes | 1 | 2022 | 91 | 0.730 |
Why?
|
| Lysosomal Storage Diseases | 2 | 2012 | 11 | 0.720 |
Why?
|
| Physician Executives | 2 | 2013 | 24 | 0.700 |
Why?
|
| Faculty, Medical | 3 | 2023 | 187 | 0.690 |
Why?
|
| Public Policy | 7 | 2008 | 59 | 0.690 |
Why?
|
| Drug Approval | 2 | 2018 | 66 | 0.680 |
Why?
|
| Pandemics | 4 | 2025 | 875 | 0.680 |
Why?
|
| Women | 4 | 2008 | 26 | 0.680 |
Why?
|
| Neoplasms | 6 | 2025 | 3169 | 0.680 |
Why?
|
| Ethics, Clinical | 5 | 2010 | 47 | 0.680 |
Why?
|
| Mass Vaccination | 1 | 2021 | 10 | 0.670 |
Why?
|
| Practice Guidelines as Topic | 14 | 2020 | 1055 | 0.670 |
Why?
|
| Kidney | 4 | 2017 | 1111 | 0.670 |
Why?
|
| Policy | 2 | 2011 | 41 | 0.670 |
Why?
|
| Curriculum | 3 | 2015 | 594 | 0.660 |
Why?
|
| Internship and Residency | 4 | 2015 | 1089 | 0.660 |
Why?
|
| Genomics | 4 | 2021 | 848 | 0.650 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2020 | 4 | 0.650 |
Why?
|
| Efficiency | 1 | 2020 | 39 | 0.650 |
Why?
|
| Ribonucleotide Reductases | 1 | 2020 | 6 | 0.650 |
Why?
|
| Health Equity | 2 | 2020 | 102 | 0.640 |
Why?
|
| Third-Party Consent | 7 | 2009 | 24 | 0.630 |
Why?
|
| Ethics | 7 | 2009 | 24 | 0.620 |
Why?
|
| Hemoglobin, Sickle | 1 | 2020 | 17 | 0.620 |
Why?
|
| Information Dissemination | 2 | 2019 | 124 | 0.620 |
Why?
|
| Intellectual Disability | 1 | 2021 | 196 | 0.620 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 184 | 0.620 |
Why?
|
| Infant, Premature | 2 | 2022 | 297 | 0.620 |
Why?
|
| Health Personnel | 3 | 2011 | 234 | 0.610 |
Why?
|
| Liver Transplantation | 4 | 2018 | 1194 | 0.610 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2025 | 2465 | 0.610 |
Why?
|
| Education, Medical, Graduate | 3 | 2015 | 427 | 0.600 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2019 | 25 | 0.600 |
Why?
|
| Craniocerebral Trauma | 1 | 2020 | 58 | 0.600 |
Why?
|
| Nephrology | 1 | 2020 | 46 | 0.590 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 891 | 0.590 |
Why?
|
| Societies, Medical | 8 | 2015 | 623 | 0.580 |
Why?
|
| Racism | 1 | 2021 | 104 | 0.580 |
Why?
|
| Tissue Banks | 3 | 2008 | 16 | 0.580 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 83 | 0.580 |
Why?
|
| Phenylketonuria, Maternal | 1 | 2018 | 1 | 0.570 |
Why?
|
| Medical History Taking | 1 | 2019 | 82 | 0.570 |
Why?
|
| Risk Factors | 14 | 2024 | 5914 | 0.560 |
Why?
|
| Medication Adherence | 1 | 2019 | 120 | 0.560 |
Why?
|
| History, 21st Century | 5 | 2021 | 187 | 0.560 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 3 | 2006 | 8 | 0.560 |
Why?
|
| Guideline Adherence | 2 | 2019 | 237 | 0.550 |
Why?
|
| Physical Examination | 1 | 2019 | 144 | 0.540 |
Why?
|
| Professional-Family Relations | 7 | 2014 | 55 | 0.540 |
Why?
|
| Interpersonal Relations | 2 | 2018 | 177 | 0.540 |
Why?
|
| Editorial Policies | 3 | 2021 | 33 | 0.540 |
Why?
|
| Leukodystrophy, Globoid Cell | 2 | 2015 | 7 | 0.540 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1232 | 0.540 |
Why?
|
| Ethics Consultation | 1 | 2018 | 12 | 0.540 |
Why?
|
| Papillomavirus Vaccines | 2 | 2008 | 59 | 0.540 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 291 | 0.540 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 409 | 0.530 |
Why?
|
| Age Factors | 11 | 2024 | 1907 | 0.530 |
Why?
|
| Paternalism | 6 | 2003 | 24 | 0.530 |
Why?
|
| Terminal Care | 2 | 2018 | 146 | 0.530 |
Why?
|
| Health Status | 3 | 2015 | 377 | 0.530 |
Why?
|
| Refusal to Treat | 3 | 2010 | 27 | 0.520 |
Why?
|
| Consensus | 3 | 2024 | 368 | 0.520 |
Why?
|
| Paternity | 3 | 2011 | 7 | 0.520 |
Why?
|
| Neuromuscular Diseases | 1 | 2017 | 27 | 0.520 |
Why?
|
| Choice Behavior | 1 | 2018 | 159 | 0.520 |
Why?
|
| Genetic Research | 3 | 2008 | 18 | 0.520 |
Why?
|
| Middle Aged | 26 | 2025 | 27621 | 0.520 |
Why?
|
| Urban Population | 1 | 2018 | 234 | 0.510 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 423 | 0.510 |
Why?
|
| Donor Selection | 4 | 2024 | 81 | 0.510 |
Why?
|
| Transplantation | 3 | 2010 | 38 | 0.510 |
Why?
|
| Sexism | 1 | 2017 | 56 | 0.510 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 176 | 0.500 |
Why?
|
| Direct-To-Consumer Screening and Testing | 2 | 2025 | 3 | 0.500 |
Why?
|
| Ethical Theory | 2 | 2016 | 10 | 0.500 |
Why?
|
| Physicians, Women | 1 | 2017 | 59 | 0.500 |
Why?
|
| Medical Errors | 2 | 2015 | 94 | 0.460 |
Why?
|
| Health Care Rationing | 2 | 2010 | 83 | 0.460 |
Why?
|
| Communication | 8 | 2025 | 434 | 0.450 |
Why?
|
| Health Services Accessibility | 5 | 2019 | 489 | 0.450 |
Why?
|
| Educational Status | 2 | 2013 | 197 | 0.450 |
Why?
|
| Clinical Competence | 2 | 2012 | 821 | 0.440 |
Why?
|
| Duty to Recontact | 1 | 2015 | 1 | 0.440 |
Why?
|
| Beneficence | 7 | 2018 | 36 | 0.440 |
Why?
|
| Coercion | 2 | 2012 | 16 | 0.430 |
Why?
|
| Therapeutic Human Experimentation | 4 | 2006 | 20 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 506 | 0.420 |
Why?
|
| Professional Competence | 2 | 2013 | 66 | 0.420 |
Why?
|
| Illinois | 5 | 2019 | 520 | 0.420 |
Why?
|
| Dissent and Disputes | 4 | 2023 | 28 | 0.420 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2015 | 91 | 0.420 |
Why?
|
| Herpes Simplex | 1 | 2015 | 79 | 0.410 |
Why?
|
| Pilot Projects | 8 | 2013 | 917 | 0.410 |
Why?
|
| Social Values | 4 | 2007 | 44 | 0.410 |
Why?
|
| Child Abuse, Sexual | 1 | 2014 | 19 | 0.410 |
Why?
|
| Psychology, Adolescent | 1 | 2014 | 26 | 0.410 |
Why?
|
| Histocompatibility | 2 | 2006 | 66 | 0.410 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 95 | 0.410 |
Why?
|
| Bone Marrow Transplantation | 2 | 2024 | 281 | 0.400 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 453 | 0.400 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2014 | 81 | 0.400 |
Why?
|
| Vaccination Coverage | 2 | 2025 | 7 | 0.400 |
Why?
|
| Adolescent Development | 2 | 2024 | 24 | 0.390 |
Why?
|
| Young Adult | 12 | 2025 | 6936 | 0.390 |
Why?
|
| Sex Factors | 4 | 2020 | 1103 | 0.390 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 110 | 0.390 |
Why?
|
| Residence Characteristics | 2 | 2012 | 213 | 0.390 |
Why?
|
| Health Physics | 1 | 2013 | 22 | 0.380 |
Why?
|
| Cadaver | 4 | 2012 | 199 | 0.380 |
Why?
|
| Codes of Ethics | 3 | 2008 | 12 | 0.380 |
Why?
|
| Infant Mortality | 1 | 2013 | 66 | 0.380 |
Why?
|
| Freedom | 7 | 1999 | 19 | 0.380 |
Why?
|
| Tyrosine | 1 | 2012 | 131 | 0.370 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 70 | 0.360 |
Why?
|
| Awareness | 1 | 2013 | 89 | 0.360 |
Why?
|
| Prejudice | 2 | 2010 | 49 | 0.360 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 54 | 0.360 |
Why?
|
| Chicago | 7 | 2018 | 1463 | 0.360 |
Why?
|
| Community Participation | 1 | 2012 | 39 | 0.350 |
Why?
|
| Cause of Death | 1 | 2013 | 273 | 0.350 |
Why?
|
| Public Opinion | 3 | 2021 | 50 | 0.350 |
Why?
|
| Health Surveys | 3 | 2013 | 245 | 0.350 |
Why?
|
| Postpartum Period | 1 | 2013 | 159 | 0.350 |
Why?
|
| Focus Groups | 5 | 2012 | 184 | 0.350 |
Why?
|
| Shame | 1 | 2011 | 3 | 0.350 |
Why?
|
| Surgery, Plastic | 1 | 2012 | 38 | 0.350 |
Why?
|
| Transplants | 2 | 2022 | 43 | 0.350 |
Why?
|
| Asthma | 3 | 2005 | 1039 | 0.350 |
Why?
|
| Athletes | 1 | 2011 | 58 | 0.340 |
Why?
|
| Self Disclosure | 1 | 2011 | 29 | 0.340 |
Why?
|
| Social Determinants of Health | 2 | 2023 | 108 | 0.340 |
Why?
|
| Comprehension | 2 | 2011 | 90 | 0.340 |
Why?
|
| Renal Dialysis | 4 | 2021 | 350 | 0.340 |
Why?
|
| Sports | 1 | 2011 | 40 | 0.340 |
Why?
|
| Surgeons | 1 | 2015 | 292 | 0.340 |
Why?
|
| Sweat | 1 | 2011 | 5 | 0.340 |
Why?
|
| Mandatory Testing | 1 | 2010 | 3 | 0.330 |
Why?
|
| Depression, Postpartum | 1 | 2011 | 12 | 0.330 |
Why?
|
| Sports Medicine | 1 | 2011 | 58 | 0.330 |
Why?
|
| Mother-Child Relations | 1 | 2010 | 31 | 0.330 |
Why?
|
| Placebos | 3 | 2005 | 206 | 0.320 |
Why?
|
| Resuscitation Orders | 2 | 2003 | 65 | 0.320 |
Why?
|
| Medical Oncology | 2 | 2021 | 403 | 0.310 |
Why?
|
| Hospital Mortality | 1 | 2013 | 483 | 0.310 |
Why?
|
| Methylmalonic Acid | 1 | 2010 | 7 | 0.310 |
Why?
|
| Immunization Programs | 3 | 2008 | 26 | 0.310 |
Why?
|
| Histocompatibility Testing | 5 | 2011 | 140 | 0.310 |
Why?
|
| Quality of Health Care | 3 | 2019 | 382 | 0.310 |
Why?
|
| Students | 1 | 2011 | 177 | 0.310 |
Why?
|
| Medicine in Literature | 1 | 2010 | 8 | 0.310 |
Why?
|
| Philosophy, Medical | 1 | 2010 | 17 | 0.310 |
Why?
|
| Risk Management | 1 | 2010 | 38 | 0.310 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2010 | 30 | 0.310 |
Why?
|
| Counseling | 3 | 2009 | 164 | 0.300 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 170 | 0.300 |
Why?
|
| Malpractice | 2 | 2002 | 47 | 0.300 |
Why?
|
| Neonatology | 2 | 2007 | 18 | 0.300 |
Why?
|
| National Health Programs | 1 | 2009 | 18 | 0.300 |
Why?
|
| Social Responsibility | 5 | 2007 | 53 | 0.300 |
Why?
|
| Health Care Surveys | 4 | 2019 | 286 | 0.290 |
Why?
|
| Dyskeratosis Congenita | 1 | 2008 | 1 | 0.290 |
Why?
|
| Fee-for-Service Plans | 1 | 2009 | 30 | 0.290 |
Why?
|
| Prenatal Care | 2 | 2013 | 80 | 0.290 |
Why?
|
| Nuclear Family | 1 | 2009 | 92 | 0.290 |
Why?
|
| Universities | 1 | 2009 | 150 | 0.290 |
Why?
|
| Anemia, Aplastic | 1 | 2008 | 32 | 0.280 |
Why?
|
| Public Health Administration | 1 | 2008 | 19 | 0.280 |
Why?
|
| Self Care | 1 | 2010 | 167 | 0.280 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2009 | 77 | 0.280 |
Why?
|
| Patient Education as Topic | 3 | 2012 | 381 | 0.280 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 151 | 0.280 |
Why?
|
| Research Support as Topic | 3 | 2010 | 89 | 0.270 |
Why?
|
| Elective Surgical Procedures | 1 | 2010 | 163 | 0.270 |
Why?
|
| Resuscitation | 1 | 2009 | 130 | 0.270 |
Why?
|
| Personhood | 2 | 2006 | 16 | 0.270 |
Why?
|
| Communicable Diseases | 1 | 2008 | 69 | 0.270 |
Why?
|
| Genetic Privacy | 3 | 2004 | 12 | 0.260 |
Why?
|
| Fetal Blood | 1 | 2008 | 95 | 0.260 |
Why?
|
| Growth | 1 | 2007 | 42 | 0.260 |
Why?
|
| Soccer | 2 | 2017 | 19 | 0.250 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2012 | 108 | 0.250 |
Why?
|
| Conscience | 1 | 2007 | 20 | 0.250 |
Why?
|
| Ethical Review | 2 | 2004 | 8 | 0.250 |
Why?
|
| Value of Life | 1 | 2007 | 23 | 0.250 |
Why?
|
| Self Report | 2 | 2019 | 329 | 0.250 |
Why?
|
| Risk-Taking | 2 | 2005 | 158 | 0.240 |
Why?
|
| Violence | 3 | 2004 | 152 | 0.240 |
Why?
|
| Publications | 2 | 2023 | 32 | 0.240 |
Why?
|
| Federal Government | 3 | 2006 | 28 | 0.240 |
Why?
|
| Patient Access to Records | 1 | 2006 | 2 | 0.240 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 270 | 0.240 |
Why?
|
| Sexuality | 2 | 1996 | 40 | 0.240 |
Why?
|
| Persistent Vegetative State | 1 | 2006 | 9 | 0.240 |
Why?
|
| School Health Services | 1 | 2006 | 16 | 0.230 |
Why?
|
| Blood Group Incompatibility | 3 | 2006 | 22 | 0.230 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 136 | 0.230 |
Why?
|
| Congresses as Topic | 2 | 2017 | 124 | 0.230 |
Why?
|
| Sex Offenses | 1 | 2006 | 22 | 0.230 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2018 | 135 | 0.230 |
Why?
|
| Models, Theoretical | 3 | 2010 | 494 | 0.230 |
Why?
|
| Congenital Abnormalities | 2 | 2003 | 66 | 0.230 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2006 | 148 | 0.230 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2008 | 318 | 0.230 |
Why?
|
| Organ Preservation | 2 | 2024 | 130 | 0.230 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 1865 | 0.220 |
Why?
|
| Papillomavirus Infections | 1 | 2008 | 300 | 0.220 |
Why?
|
| Australia | 2 | 2021 | 123 | 0.220 |
Why?
|
| Algorithms | 3 | 2015 | 1954 | 0.220 |
Why?
|
| Contraception | 2 | 1996 | 100 | 0.220 |
Why?
|
| Genetics, Behavioral | 1 | 2004 | 22 | 0.220 |
Why?
|
| Legal Guardians | 2 | 2006 | 7 | 0.220 |
Why?
|
| Glucose Clamp Technique | 1 | 2004 | 42 | 0.210 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2005 | 93 | 0.210 |
Why?
|
| Parenting | 2 | 2020 | 62 | 0.210 |
Why?
|
| Family Health | 2 | 2004 | 153 | 0.200 |
Why?
|
| Prognosis | 6 | 2018 | 3915 | 0.200 |
Why?
|
| Emotions | 2 | 2019 | 371 | 0.200 |
Why?
|
| Aged | 10 | 2018 | 20469 | 0.200 |
Why?
|
| Safety | 2 | 2020 | 132 | 0.190 |
Why?
|
| State Government | 2 | 2020 | 24 | 0.190 |
Why?
|
| Civil Rights | 3 | 1997 | 8 | 0.190 |
Why?
|
| Perfusion | 1 | 2024 | 260 | 0.190 |
Why?
|
| Organizational Policy | 2 | 2003 | 57 | 0.190 |
Why?
|
| Obstetrics | 1 | 2004 | 123 | 0.180 |
Why?
|
| Prevalence | 2 | 2021 | 1322 | 0.180 |
Why?
|
| Developmental Disabilities | 1 | 2024 | 204 | 0.180 |
Why?
|
| Public Housing | 1 | 2002 | 9 | 0.180 |
Why?
|
| Lead Poisoning | 1 | 2002 | 13 | 0.180 |
Why?
|
| Religion and Medicine | 2 | 2007 | 122 | 0.170 |
Why?
|
| Canada | 3 | 2009 | 194 | 0.170 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 111 | 0.170 |
Why?
|
| Hemoglobinopathies | 2 | 2011 | 9 | 0.170 |
Why?
|
| Advisory Committees | 2 | 2018 | 90 | 0.170 |
Why?
|
| Pancreas Transplantation | 1 | 2021 | 104 | 0.170 |
Why?
|
| Neurologists | 1 | 2021 | 8 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2018 | 962 | 0.160 |
Why?
|
| Culture | 3 | 2009 | 54 | 0.160 |
Why?
|
| Interviews as Topic | 2 | 2015 | 363 | 0.160 |
Why?
|
| AIDS Serodiagnosis | 1 | 2001 | 26 | 0.160 |
Why?
|
| Prospective Studies | 4 | 2021 | 4563 | 0.160 |
Why?
|
| Informed Consent By Minors | 1 | 2020 | 2 | 0.160 |
Why?
|
| Patient Self-Determination Act | 1 | 2020 | 4 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 146 | 0.160 |
Why?
|
| Principle-Based Ethics | 1 | 2020 | 4 | 0.160 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 356 | 0.160 |
Why?
|
| Pancreatic Diseases | 1 | 2001 | 58 | 0.160 |
Why?
|
| Interinstitutional Relations | 1 | 2000 | 29 | 0.160 |
Why?
|
| Patient Care | 3 | 1999 | 97 | 0.160 |
Why?
|
| Thymidine Kinase | 1 | 2020 | 30 | 0.160 |
Why?
|
| Crowdsourcing | 1 | 2020 | 12 | 0.160 |
Why?
|
| Creativity | 1 | 2020 | 5 | 0.160 |
Why?
|
| Genetics, Medical | 4 | 2014 | 51 | 0.160 |
Why?
|
| Morbidity | 1 | 2021 | 162 | 0.160 |
Why?
|
| New York City | 1 | 2020 | 69 | 0.160 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 11 | 0.160 |
Why?
|
| Twins, Monozygotic | 1 | 2020 | 58 | 0.160 |
Why?
|
| Conflict of Interest | 3 | 2010 | 70 | 0.160 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 224 | 0.160 |
Why?
|
| Goals | 3 | 1996 | 66 | 0.160 |
Why?
|
| Medical Futility | 1 | 2020 | 34 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 767 | 0.160 |
Why?
|
| Access to Information | 2 | 2015 | 29 | 0.160 |
Why?
|
| Proxy | 1 | 2020 | 27 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 306 | 0.160 |
Why?
|
| Rheumatic Fever | 1 | 2019 | 12 | 0.160 |
Why?
|
| Penicillins | 1 | 2019 | 24 | 0.150 |
Why?
|
| Drug Industry | 1 | 2000 | 56 | 0.150 |
Why?
|
| Education, Medical | 1 | 2022 | 228 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2024 | 876 | 0.150 |
Why?
|
| Men | 2 | 1996 | 10 | 0.150 |
Why?
|
| Democracy | 2 | 1996 | 4 | 0.150 |
Why?
|
| Tay-Sachs Disease | 2 | 2011 | 6 | 0.150 |
Why?
|
| Deception | 2 | 1996 | 19 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2006 | 826 | 0.150 |
Why?
|
| Patient Transfer | 1 | 2020 | 108 | 0.150 |
Why?
|
| Dialysis | 1 | 2019 | 22 | 0.150 |
Why?
|
| Netherlands | 1 | 2019 | 25 | 0.150 |
Why?
|
| Global Health | 1 | 2021 | 208 | 0.150 |
Why?
|
| Jews | 2 | 2011 | 42 | 0.150 |
Why?
|
| Genome, Human | 2 | 2015 | 823 | 0.150 |
Why?
|
| Thanatology | 1 | 2018 | 1 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2002 | 355 | 0.140 |
Why?
|
| DNA, Recombinant | 1 | 2018 | 60 | 0.140 |
Why?
|
| Attitude to Death | 1 | 2018 | 36 | 0.140 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 18 | 0.140 |
Why?
|
| HLA Antigens | 2 | 2010 | 228 | 0.140 |
Why?
|
| Privacy | 3 | 2010 | 20 | 0.140 |
Why?
|
| Volition | 1 | 2018 | 17 | 0.140 |
Why?
|
| Hymen | 1 | 1998 | 1 | 0.140 |
Why?
|
| Delayed Graft Function | 1 | 2018 | 16 | 0.140 |
Why?
|
| Ectromelia | 1 | 2018 | 4 | 0.140 |
Why?
|
| Ethylene Glycols | 1 | 2018 | 10 | 0.140 |
Why?
|
| Program Evaluation | 2 | 2009 | 315 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2020 | 219 | 0.130 |
Why?
|
| Thalidomide | 1 | 2018 | 55 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2000 | 397 | 0.130 |
Why?
|
| Genetic Therapy | 2 | 2018 | 365 | 0.130 |
Why?
|
| Genetic Services | 1 | 1997 | 7 | 0.130 |
Why?
|
| Advance Directive Adherence | 1 | 1997 | 7 | 0.130 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 1014 | 0.130 |
Why?
|
| Christianity | 1 | 1997 | 36 | 0.130 |
Why?
|
| Circumcision, Male | 1 | 1997 | 19 | 0.130 |
Why?
|
| Patient Preference | 2 | 2016 | 125 | 0.130 |
Why?
|
| Trust | 2 | 2012 | 97 | 0.130 |
Why?
|
| Mutation | 2 | 2023 | 4266 | 0.130 |
Why?
|
| Psychology, Child | 2 | 2014 | 12 | 0.130 |
Why?
|
| Iatrogenic Disease | 1 | 1997 | 69 | 0.130 |
Why?
|
| Hockey | 1 | 2017 | 9 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 889 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 139 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.130 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 120 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2008 | 1715 | 0.120 |
Why?
|
| Apolipoprotein L1 | 1 | 2016 | 7 | 0.120 |
Why?
|
| Social Control, Formal | 1 | 1996 | 10 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 990 | 0.120 |
Why?
|
| Diseases in Twins | 1 | 2016 | 64 | 0.120 |
Why?
|
| Nephrectomy | 2 | 2008 | 293 | 0.120 |
Why?
|
| Fathers | 1 | 1996 | 44 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3837 | 0.120 |
Why?
|
| International Cooperation | 1 | 2016 | 133 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1923 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1165 | 0.120 |
Why?
|
| Patient Harm | 1 | 2015 | 7 | 0.110 |
Why?
|
| Quality of Life | 3 | 2021 | 1783 | 0.110 |
Why?
|
| Consent Forms | 2 | 2006 | 11 | 0.110 |
Why?
|
| Medicare | 1 | 2019 | 455 | 0.110 |
Why?
|
| Unsafe Sex | 1 | 2015 | 45 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.110 |
Why?
|
| Chickenpox | 1 | 1995 | 12 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.110 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2015 | 17 | 0.110 |
Why?
|
| Peer Review, Research | 2 | 2010 | 37 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 1995 | 21 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 34 | 0.110 |
Why?
|
| Viral Vaccines | 1 | 1995 | 37 | 0.110 |
Why?
|
| Sexual Abstinence | 2 | 2008 | 10 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2024 | 9109 | 0.110 |
Why?
|
| Epidemiologic Factors | 2 | 2005 | 5 | 0.110 |
Why?
|
| Mental Health | 1 | 2015 | 189 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 185 | 0.100 |
Why?
|
| Immunization Schedule | 1 | 2013 | 23 | 0.100 |
Why?
|
| Quadriplegia | 1 | 1993 | 31 | 0.100 |
Why?
|
| Heart Transplantation | 1 | 2019 | 814 | 0.100 |
Why?
|
| Diet | 1 | 2016 | 460 | 0.100 |
Why?
|
| Religion | 2 | 2008 | 89 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2014 | 164 | 0.100 |
Why?
|
| Time Factors | 4 | 2024 | 5406 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2015 | 347 | 0.100 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2012 | 2 | 0.090 |
Why?
|
| New York | 1 | 2012 | 78 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1918 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2018 | 1123 | 0.090 |
Why?
|
| Age of Onset | 2 | 2003 | 342 | 0.090 |
Why?
|
| Logistic Models | 1 | 2015 | 1245 | 0.090 |
Why?
|
| Benchmarking | 1 | 2012 | 80 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 367 | 0.090 |
Why?
|
| Genotype | 1 | 2016 | 1866 | 0.090 |
Why?
|
| Brain | 1 | 2022 | 2375 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 441 | 0.080 |
Why?
|
| Brazil | 1 | 2011 | 81 | 0.080 |
Why?
|
| Carrier State | 1 | 2010 | 40 | 0.080 |
Why?
|
| Health Education | 1 | 2011 | 105 | 0.080 |
Why?
|
| Negotiating | 1 | 2010 | 19 | 0.080 |
Why?
|
| United States Office of Research Integrity | 2 | 2013 | 2 | 0.080 |
Why?
|
| Chimera | 1 | 2010 | 52 | 0.080 |
Why?
|
| Gynecology | 1 | 2011 | 130 | 0.080 |
Why?
|
| Training Support | 1 | 2009 | 22 | 0.080 |
Why?
|
| Mosaicism | 1 | 2010 | 73 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2010 | 580 | 0.070 |
Why?
|
| Hospitals, University | 2 | 2002 | 188 | 0.070 |
Why?
|
| Professional-Patient Relations | 2 | 2002 | 48 | 0.070 |
Why?
|
| Accreditation | 1 | 2009 | 74 | 0.070 |
Why?
|
| Demography | 1 | 2009 | 190 | 0.070 |
Why?
|
| Reimbursement, Incentive | 1 | 2009 | 36 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2023 | 10185 | 0.070 |
Why?
|
| Poverty | 1 | 2010 | 193 | 0.070 |
Why?
|
| Papanicolaou Test | 1 | 2008 | 39 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 242 | 0.070 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2008 | 6 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 2 | 2002 | 225 | 0.070 |
Why?
|
| ROC Curve | 1 | 2011 | 775 | 0.070 |
Why?
|
| Vaginal Smears | 1 | 2008 | 71 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2010 | 219 | 0.070 |
Why?
|
| Program Development | 1 | 2009 | 131 | 0.070 |
Why?
|
| Family Practice | 1 | 2008 | 73 | 0.070 |
Why?
|
| Incidence | 1 | 2013 | 1702 | 0.070 |
Why?
|
| Cultural Diversity | 2 | 2021 | 63 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2009 | 214 | 0.070 |
Why?
|
| Telomere | 1 | 2008 | 120 | 0.070 |
Why?
|
| Ethics Committees | 2 | 2008 | 9 | 0.070 |
Why?
|
| Obesity | 2 | 2004 | 1019 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2009 | 252 | 0.060 |
Why?
|
| Growth Hormone | 1 | 2007 | 97 | 0.060 |
Why?
|
| Euthanasia | 1 | 2007 | 17 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 2566 | 0.060 |
Why?
|
| Hemophilia A | 1 | 2006 | 6 | 0.060 |
Why?
|
| Alleles | 1 | 2010 | 1139 | 0.060 |
Why?
|
| Uncertainty | 1 | 2007 | 78 | 0.060 |
Why?
|
| Wisconsin | 1 | 2006 | 44 | 0.060 |
Why?
|
| Colorado | 1 | 2006 | 39 | 0.060 |
Why?
|
| Florida | 1 | 2006 | 61 | 0.060 |
Why?
|
| Student Health Services | 1 | 2006 | 1 | 0.060 |
Why?
|
| Quebec | 1 | 2006 | 11 | 0.060 |
Why?
|
| Medicaid | 1 | 2009 | 259 | 0.060 |
Why?
|
| Group Processes | 2 | 1997 | 30 | 0.060 |
Why?
|
| Adult Children | 1 | 2006 | 13 | 0.060 |
Why?
|
| Fertility | 1 | 2006 | 119 | 0.060 |
Why?
|
| Medically Uninsured | 1 | 2005 | 67 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 543 | 0.060 |
Why?
|
| Reference Standards | 1 | 2005 | 146 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 154 | 0.060 |
Why?
|
| Delayed Diagnosis | 1 | 2025 | 41 | 0.060 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2004 | 12 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 3158 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2005 | 180 | 0.050 |
Why?
|
| Reproduction | 1 | 2005 | 205 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 198 | 0.050 |
Why?
|
| Patient Dropouts | 1 | 2004 | 31 | 0.050 |
Why?
|
| Psychology | 1 | 2003 | 26 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 298 | 0.050 |
Why?
|
| Social Environment | 1 | 2004 | 194 | 0.050 |
Why?
|
| Organ Size | 1 | 2024 | 361 | 0.050 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2003 | 5 | 0.050 |
Why?
|
| Sample Size | 1 | 2003 | 128 | 0.050 |
Why?
|
| Voluntary Programs | 1 | 2002 | 1 | 0.050 |
Why?
|
| Child, Hospitalized | 1 | 2003 | 41 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1191 | 0.050 |
Why?
|
| Contraception Behavior | 1 | 2003 | 30 | 0.050 |
Why?
|
| Hearing Tests | 1 | 2022 | 11 | 0.050 |
Why?
|
| Reading | 1 | 2022 | 33 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2003 | 117 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2003 | 137 | 0.050 |
Why?
|
| Anecdotes as Topic | 1 | 2002 | 14 | 0.040 |
Why?
|
| Adoption | 1 | 2001 | 9 | 0.040 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2002 | 20 | 0.040 |
Why?
|
| Baltimore | 1 | 2002 | 41 | 0.040 |
Why?
|
| Maryland | 1 | 2002 | 45 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 71 | 0.040 |
Why?
|
| Consciousness | 1 | 2022 | 28 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 111 | 0.040 |
Why?
|
| Social Discrimination | 1 | 2021 | 7 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 603 | 0.040 |
Why?
|
| Social Class | 1 | 2002 | 142 | 0.040 |
Why?
|
| Brain Stem | 1 | 2022 | 163 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 19 | 0.040 |
Why?
|
| Stereotyping | 1 | 2001 | 17 | 0.040 |
Why?
|
| Information Services | 1 | 2001 | 22 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2002 | 159 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2718 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 7072 | 0.040 |
Why?
|
| Probability | 1 | 2001 | 355 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2002 | 144 | 0.040 |
Why?
|
| Decision Trees | 1 | 2000 | 64 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2003 | 328 | 0.040 |
Why?
|
| Animals | 1 | 2019 | 28041 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2019 | 38 | 0.040 |
Why?
|
| Patients | 1 | 2000 | 104 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2002 | 224 | 0.040 |
Why?
|
| Advance Care Planning | 1 | 2000 | 44 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 2000 | 191 | 0.040 |
Why?
|
| Societies | 1 | 1999 | 14 | 0.040 |
Why?
|
| Containment of Biohazards | 1 | 2018 | 8 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 240 | 0.040 |
Why?
|
| Learning | 1 | 2021 | 292 | 0.040 |
Why?
|
| Patient Safety | 1 | 2021 | 219 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 485 | 0.030 |
Why?
|
| Academies and Institutes | 2 | 2008 | 34 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 116 | 0.030 |
Why?
|
| Behavioral Research | 1 | 1997 | 11 | 0.030 |
Why?
|
| Refusal to Participate | 1 | 1997 | 2 | 0.030 |
Why?
|
| Intention | 1 | 1997 | 52 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 282 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2000 | 379 | 0.030 |
Why?
|
| Rape | 1 | 1996 | 17 | 0.030 |
Why?
|
| Jurisprudence | 1 | 1996 | 24 | 0.030 |
Why?
|
| Education | 1 | 1996 | 59 | 0.030 |
Why?
|
| Parental Notification | 1 | 1996 | 7 | 0.030 |
Why?
|
| Social Change | 1 | 1996 | 9 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1525 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 1998 | 757 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 110 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1997 | 109 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2015 | 91 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 240 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 1995 | 137 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 1951 | 0.030 |
Why?
|
| Politics | 1 | 1994 | 51 | 0.030 |
Why?
|
| Patient Rights | 1 | 2013 | 16 | 0.020 |
Why?
|
| Penetrance | 1 | 2013 | 48 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2013 | 22 | 0.020 |
Why?
|
| Individuality | 1 | 1994 | 114 | 0.020 |
Why?
|
| Human Body | 1 | 1993 | 7 | 0.020 |
Why?
|
| Exome | 1 | 2013 | 141 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1994 | 409 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1993 | 109 | 0.020 |
Why?
|
| HIV Infections | 1 | 2001 | 955 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 537 | 0.020 |
Why?
|
| Cognition | 1 | 1995 | 627 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2009 | 14 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2013 | 1119 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 768 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 494 | 0.020 |
Why?
|
| Pedigree | 1 | 2004 | 961 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2001 | 33 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2001 | 128 | 0.010 |
Why?
|